title: Omalizumab dosing via the recommended card versus use of the published formula.
authors.forename: Todd
authors.initials: T
authors.lastname: Rambasek
authors.forename: Mani S
authors.initials: MS
authors.lastname: Kavuru
mesh_terms: D018927:Anti-Asthmatic Agents / Q000008:administration & dosage*; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000191:economics; D061067:Antibodies, Monoclonal, Humanized; D001249:Asthma / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D016527:Drug Costs; D006801:Humans; D007073:Immunoglobulin E; D000069444:Omalizumab; D012189:Retrospective Studies
chemical_list: D018927:Anti-Asthmatic Agents; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069444:Omalizumab; D007073:Immunoglobulin E